AbbVie at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
AbbVie brings 2 presentations to IDWeek 2026 in Washington, and exhibits at Booth 1414, BS 9. Its program centres on gram-negative bacterial infections and what surveillance data reveal about them. It reviews lab and clinical data on treatment options for gram-negative infections.
| Organization | IDWeek 2026 Attendance |
|---|---|
AbbVie North Chicago, IL | |
Global biopharmaceutical company that discovers and sells medicines for serious conditions across several therapeutic areas. | Booth Exhibiting at Booth 1414, BS 9 Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm Industry Thu Oct 22 12:15pm–1:00pm Industry Fri Oct 23 12:15pm–1:00pm In Vitro Data and Clinical Profile Review of Two Treatment Options for Gram-Negative Infections Antimicrobials, resistance and stewardship |
Instantly find 20 buyers from AbbVie
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction